We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BRRGF market cap is 67.22M. The company's latest EPS is NOK -0.1124 and P/E is -0.18.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 2.34M | 8.9M | 601k | 774k | 389k |
| Operating Income | -194.54M | -204.37M | -261.09M | -314.46M | -305.64M |
| Net Income | -191.75M | -199.28M | -257.03M | -309.36M | -302.12M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 378.83M | 270.38M | 738.2M | 450.24M | 166.71M |
| Total Liabilities | 41.55M | 50.62M | 67.97M | 65.81M | 78.21M |
| Total Equity | 337.28M | 219.75M | 670.23M | 384.43M | 88.5M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -186.71M | -184.15M | -234.29M | -303.34M | -288.23M |
| Investing | -228k | N/A | 3.55M | 3.13M | 3.25M |
| Financing | 177M | 77.32M | 699.51M | 15.99M | 2.9M |
| Market Cap | 67.22M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 200 |
| Price to Cash Ratio | 0.58 |
| Price to Book Ratio | 0.61 |
| Dividend Yield | - |
| Shares Outstanding | 2.69B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.025 |
| 52 Week Low | 0.025 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bergenbio AS (CE) |
| Address |
jonas lies vei 91 bergen 5009 |
| Website | https://www.bergenbio.com |
| Industry | meas & controlling dev, nec (3829) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
